Richard E. Clark

48.5k citations
246 papers · 16.4k · 7 hit papers · h-index 57

Impact in

  • Hematology top 0.05%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 2%

Papers in

    • Chronic Myeloid Leukemia Treatments 137
    • Acute Myeloid Leukemia Research 39
    • Hematopoietic Stem Cell Transplantation 25
    • Multiple Myeloma Research and Treatments 4
    • Immunotherapy and Immune Responses 11

Richard E. Clark

243 papers receiving 15.9k citations

Richard E. Clark's Hit Papers

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia 2025 · 29 citations
290+5+10Years since publication5001k1.5k

Peers

Richard E. Clark
Comparison fields: 5 of 117
  • Hematology 11.8k
  • Genetics 420
  • Oncology 1k
  • Immunology 843
  • Pharmacology 393
Replace Delphine Réa with:
Delphine Réa France
Bengt Simonsson Sweden
Stephen G. O’Brien United Kingdom
Insa Gathmann Switzerland
Gabriel Étienne France
François‐Xavier Mahon France
Debra J. Resta United States
Philipp le Coutre Germany
Kerry McDonald Taylor Australia
Johan Lanng Nielsen Denmark
Richard E. Clark relative to Delphine Réa France Delphine Réa's profile →
Citations per field
00.5×2×2.6×
Delphine Réa · 1×
Citations per year

Countries citing papers authored by Richard E. Clark

Since Specialization
Citations

This map shows the geographic impact of Richard E. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Clark more than expected).

Fields of papers citing papers by Richard E. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Clark. The network helps show where Richard E. Clark may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard E. Clark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard E. Clark Line = papers co-authored together Richard E. Clark links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 246 papers — load more, or switch the sort, to bring in the rest.

#Work
1
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Hit paper breakdown →
20131620
2
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Hit paper breakdown →
20101387
3
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hit paper breakdown →
20201091
4
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
Hit paper breakdown →
2016676
5 2004536
6 2015425
7
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
Hit paper breakdown →
2016401
8 2011394
9 2001384
10 2012363
11 2006342
12 2007323
13 2009300
14
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Hit paper breakdown →
2021250
15 2015245
16 2007233
17 2016229
18 2001219
19
Thrombotic microangiopathy following bone marrow transplantation.
1994213
20 2015194

About Richard E. Clark

Richard E. Clark is a scholar working on Hematology, Immunology, Oncology, Molecular Biology and Genetics, having authored 246 papers that have together received 16.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (137 papers), Acute Myeloid Leukemia Research (39 papers), Hematopoietic Stem Cell Transplantation (25 papers), Drug Transport and Resistance Mechanisms (12 papers), Immunotherapy and Immune Responses (11 papers), RNA Interference and Gene Delivery (9 papers), Retinoids in leukemia and cellular processes (8 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Hematology (11.8k citations), Genetics (420 citations), Oncology (1k citations), Immunology (843 citations) and Pharmacology (393 citations). Richard E. Clark has collaborated with scholars based in United Kingdom, Germany and Italy. Frequent co-authors include Munir Pirmohamed, Andreas Hochhaus, Alan K. Burnett, Giuseppe Nicola Saglio, Timothy P. Hughes, Richard A. Larson, Hagop M. Kantarjian, Gabriel Étienne, Claire Lucas and Surapol Issaragrisil. Their work appears in journals such as Blood, Leukemia, British Journal of Haematology, Haematologica and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact